英文名稱(chēng) Anti-CD109

中文名稱(chēng) 轉(zhuǎn)化生長(zhǎng)因子β1結(jié)合蛋白抗體

濃 度 1mg/1ml

規(guī) 格 0.1ml/100μg 0.2ml/200μg

抗體來(lái)源 Rabbit

交叉反應(yīng) Human, Mouse, Rat, Dog, Pig, Cow, Horse

產(chǎn)品類(lèi)型 一抗

研究領(lǐng)域 腫瘤 免疫學(xué) 細(xì)胞表面分子 糖蛋白 淋巴細(xì)胞 t-淋巴細(xì)胞

蛋白分子量 predicted molecular weight: 154kDa

性 狀 Lyophilized or Liquid

免 疫 原 KLH conjugated synthetic peptide derived from humanCD109

亞 型 IgG

純化方法 affinity purified by Protein A

儲(chǔ) 存 液 0.01M PBS, pH 7.4 with 10 mg/ml BSA and 0.1% Soiumzde

產(chǎn)品應(yīng)用 WB=1:100-500 ELISA=1:500-1000 IP=1:20-100 IHC-P=1:100-500IHC-F=1:100-500 IF=1:100-500

（石蠟切片需做抗原修復(fù)）

not yet tested in other applications.

optimal dilutions/concentrations should be determined by theend user.

保存條件  Store at -20 °C for one year.

別 名 p180; 8A3; 150 KDa TGF beta 1 binding protein; 7D1;DKFZp762L1111; E123; Platelet specific Gov antigen; r150; RP11 525G3.1;Activated T cell marker CD109; CD 109 antibody CD109 antigen; CPAMD7; FLJ38569;FLJ41966; Gov system alloantigens on platelets.